The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women

Atherosclerosis

Volumn 157, Issue 2, 2001, Pages 471-479

  Koivu, Tommi A ^a,b   Dastidar, Prasun ^a,c   Jokela, Hannu ^a   Nikkari, Seppo T ^a,b   Jaakkola, Olli ^b   Koivula, Timo ^a   Punnonen, Reijo ^a,c   Lehtimäki, Terho ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Atherosclerosis; Hormone replacement therapy; LDL oxidation; Sonography

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; AUTOANTIBODY; ESTRADIOL VALERATE; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVONORGESTREL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; OXIDATION; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

AGED; ARTERIES; ARTERIOSCLEROSIS; AUTOANTIBODIES; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LEVONORGESTREL; LIPOPROTEINS, LDL; MEDROXYPROGESTERONE 17-ACETATE; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE CONGENERS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0034895589     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00751-6     Document Type: Article

References (42)

1. Menopausal oestrogen therapy and protection from death from ischaemic heart disease
2. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The atherosclerosis risk in communities study investigators
3. Postmenopausal hormone replacement therapy and cardiovascular disease
4. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
5. Combined oestrogen-progestin replacement therapy prevents atherosclerosis in postmenopausal women
6. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis
7. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL
8. Low density lipoprotein undergoes oxidative modification in vivo
9. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
10. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
11. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
12. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
13. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease
14. Antibody against oxidized low-density lipoprotein predicting myocardial infarction
15. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL
16. In vivo low density lipoprotein oxidation relates to coronary reactivity in young men
17. Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features
18. Ultrasonic tissue characterization of atheromatous plaques using a high resolution real time scanner
19. Carotid plaque hemorrhage. Its role in production of cerebral ischemia
20. The carotid bifurcation plaque: Pathologic findings associated with cerebral ischemia
21. Improved method for separation of total HDL cholesterol and subclasses
22. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
23. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum
24. Estrogen and coronary heart disease in women
25. Menopause and risk of cardiovascular disease: The Framingham study
26. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
27. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits
28. Decreased in vitro production of 6-keto-prostaglandin F1 alpha by uterine arteries from postmenopausal women
29. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women
30. The protective effects of estrogen on the cardiovascular system
31. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
32. The HERS trial results: Paradigms lost? Heart and estrogen/progestin replacement study
33. Myocardial infarction and estrogen therapy in post-menopausal women
34. Menopause and coronary heart disease. The Framingham study
35. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy
36. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women
37. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women
38. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis
39. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein
40. Estrogens as natural antioxidants of membrane phospholipid peroxidation
41. Pathogenesis of atherosclerosis
42. Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL